How should women with pre-eclampsia be followed up? New insights from mechanistic studies

Nature Clinical Practice Nephrology

Volumn 4, Issue 9, 2008, Pages 503-509

  Hertig, Alexandre ^a   Watnick, Suzanne ^b   Strevens, Helena ^c   Boulanger, Henri ^d   Berkane, Nadia ^a   Rondeau, Eric ^a  

^a HÔPITAL TENON   (France)

^b PORTLAND VA MEDICAL CENTER   (United States)

^c LUND UNIVERSITY   (Sweden)

^d Service of Nephrology and Dialysis   (France)

Author keywords

Gestational hypertension; Glomerular endotheliosis; Pre eclampsia; Pregnancy; sFlt 1

Indexed keywords

ANGIOGENIC FACTOR; AUTOANTIBODY; FIBROBLAST GROWTH FACTOR RECEPTOR 1; VASCULOTROPIN;

BLOOD VESSEL FUNCTION; CARDIOVASCULAR RISK; ENDOTHELIUM; EXERCISE TEST; FEMALE; FETUS OUTCOME; FOLLOW UP; GLOMERULOPATHY; GLOMERULUS; GLOMERULUS CAPILLARY; HUMAN; KIDNEY FUNCTION TEST; LIFESTYLE MODIFICATION; MATERNAL CARE; MATERNAL WELFARE; PATHOPHYSIOLOGY; PATIENT MONITORING; PLACENTA; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; REVIEW; SCREENING; THROMBOPHILIA;

ANTIGENS, CD; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CONTINUITY OF PATIENT CARE; FEMALE; HUMANS; KIDNEY DISEASES; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RECEPTORS, CELL SURFACE; RISK FACTORS; THROMBOPHILIA; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 50249147366     PISSN: 17458323     EISSN: 17458331     Source Type: Journal    
DOI: 10.1038/ncpneph0880     Document Type: Review

References (59)

1. Sibai B et al. (2005) Pre-eclampsia. Lancet 365: 785-799
2. Maynard SE et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 111: 649-658
3. Mignini LE (2006) Mapping the theories of preeclampsia: the need for systematic reviews of mechanisms of the disease. Am J Obstet Gynecol 194: 317-321
4. Luttun A and Carmeliet P (2003) Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? J Clin Invest 111: 600-602
5. Schaffer NK et al. (1943) Uric acid clearance in normal pregnancy and pre-eclampsia. J Clin Invest 22: 201-206
6. Groopman J (online 24 June 2006) The preeclampsia puzzle: making sense of a mysterious pregnancy disorder. The New Yorker [http://www.newyorker. com/archive/2006/07/24/060724fa_fact] (accessed 6 June 2008)
7. Chaiworapongsa T et al. (2004) Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol 190: 1541-1547
8. Hertig A et al. (2004) Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia. Clin Chem 50: 1702-1703
9. McKeeman GC et al. (2004) Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol 191: 1240-1246
10. Shibata E et al. (2005) Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 90: 4895-4903
11. Tsatsaris V et al. (2003) Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 88: 5555-5563
12. Wathen KA et al. (2006) Maternal serum-soluble vascular endothelial growth factor receptor-1 in early pregnancy ending in preeclampsia or intrauterine growth retardation. J Clin Endocrinol Metab 91: 180-184
13. Levine RJ et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 350: 672-683
14. Berkane N et al. (2008) Hypertensive disorders of pregnancy: future perspectives. A French point of view. Curr Opin Obstet Gynecol 20: 107-109
15. Sugimoto H et al. (2003) Neutralization of circulating vascular endothelial growth factor (VEGF) by anti-VEGF antibodies and soluble VEGF receptor 1 (sFlt-1) induces proteinuria. J Biol Chem 278: 12605-12608
16. Eremina V et al. (2003) Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest 111: 707-716
17. Ostendorf T et al. (1999) VEGF(165) mediates glomerular endothelial repair. J Clin Invest 104: 913-923
18. Berkane N et al. (2007) Angiogenic factors in preeclampsia: so complex, so simple? Nephrol Dial Transplant 22: 2753-2756
19. Shimizu A et al. (2004) Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis. J Am Soc Nephrol 15: 2655-2665
20. Kabbinavar F et al. (2003) Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. J Clin Oncol 21: 60-65
21. Eremina V et al. (2008) VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med 358: 1129-1136
22. Ferrara N and Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438: 967-974
23. Yoshimatsu J et al. (2006) Relationship between urinary albumin and serum soluble fms-like tyrosine kinase 1 (sFlt-1) in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 128: 204-208
24. Strevens H et al. (2003) Glomerular endotheliosis in normal pregnancy and pre-eclampsia. BJOG 110: 831-836
25. Murakami S et al. (2000) Renal disease in women with severe preeclampsia or gestational proteinuria. Obstet Gynecol 96: 945-949
26. Levine RJ et al. (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355: 992-1005
27. Lopez-Espinoza I et al. (1986) Urinary albumin excretion in pregnancy. BJOG 93: 176-181
28. Misiani R et al. (1991) Urinary albumin excretion in normal pregnancy and pregnancy-induced hypertension. Nephron 59: 416-422
29. Hladunewich MA et al. (2008) Course of preeclamptic glomerular injury after delivery. Am J Physiol Renal Physiol 294: F614-F620
30. Bar J et al. (1999) Microalbuminuria after pregnancy complicated by pre-eclampsia. Nephrol Dial Transplant 14: 1129-1132
31. Nisell H et al. (1995) Blood pressure and renal function seven years after pregnancy complicated by hypertension. BJOG 102: 876-881
32. Vikse BE et al. (2006) Adverse perinatal outcome and later kidney biopsy in the mother. J Am Soc Nephrol 17: 837-845
33. Sibai BM et al. (1986) Severe preeclampsia-eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 155: 1011-1016
34. Pouta A et al. (2004) Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension 43: 825-831
35. Irgens HU et al. (2001) Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 323: 1213-1217
36. Ray JG et al. (2005) Cardiovascular health after maternal placental syndromes (CHAMPS): population-based retrospective cohort study. Lancet 366: 1797-1803
37. Wilson BJ et al. (2003) Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 326: 845
38. Smith GC et al. (2001) Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357: 2002-2006
39. Lawlor DA et al. (2005) Birth weight is inversely associated with incident coronary heart disease and stroke among individuals born in the 1950s: findings from the Aberdeen Children of the 1950s prospective cohort study. Circulation 112: 1414-1418
40. Sibai BM (1996) Treatment of hypertension in pregnant women. N Engl J Med 335: 257-265
41. Higgins JR and de Swiet M (2001) Blood-pressure measurement and classification in pregnancy. Lancet 357: 131-135
42. Salahuddin S et al. (2007) Diagnostic utility of soluble fms-like tyrosine kinase 1 and soluble endoglin in hypertensive diseases of pregnancy. Am J Obstet Gynecol 197: 28.e1-28.e6
43. He H et al. (1999) Vascular endothelial growth factor signals endothelial cell production of nitric oxide and prostacyclin through flk-1/KDR activation of c-Src. J Biol Chem 274: 25130-25135
44. Venkatesha S et al. (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12: 642-649
45. Hertig A et al. (2007) Soluble endoglin levels during normotensive and hypertensive pregnancies. Eur J Obstet Gynecol Reprod Biol [doi:10.1016/j.ejogrb.2007.09.007]
46. Villar J et al. (2006) Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions? Am J Obstet Gynecol 194: 921-931
47. Fisher KA et al. (1981) Hypertension in pregnancy: clinical-pathological correlations and remote prognosis. Medicine (Baltimore) 60: 267-276
48. Alfirevic Z et al. (2002) How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 101: 6-14
49. Kupferminc MJ (2003) Thrombophilia and pregnancy. Reprod Biol Endocrinol 1: 111
50. Johansen M et al. (1999) Trophoblast deportation in human pregnancy - its relevance for pre-eclampsia. Placenta 20: 531-539
51. Germain SJ et al. (2007) Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol 178: 5949-5956
52. Lin J and August P (2005) Genetic thrombophilias and preeclampsia: a meta-analysis. Obstet Gynecol 105: 182-192
53. Zhou CC et al. (2008) Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling. Hypertension 51: 1010-1019
54. Wallukat G et al. (1999) Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. J Clin Invest 103: 945-952
55. Karumanchi SA and Lindheimer MD (2008) Preeclampsia pathogenesis: "triple a rating"-autoantibodies and antiangiogenic factors. Hypertension 51: 991-992
56. Subramanya A et al. (2005) Steroid-responsive idiopathic glomerular capillary endotheliosis: case report and literature review. Am J Kidney Dis 45: 1090-1095
57. Matthiesen LS et al. (1999) A prospective study on the occurrence of autoantibodies in low-risk pregnancies. Eur J Obstet Gynecol Reprod Biol 83: 21-26
58. Kanasaki K et al. (2008) Deficiency in catechol-O- methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia. Nature [doi:10. 1038/nature06951]
59. Qazi U et al. (2008) Soluble fms-like tyrosine kinase associated with preeclampsia in pregnancy in systemic lupus erythematosus. J Rheumatol 35: 631-634